April 2021: Infectious Disease

Industry News Round-up

What’s new in infectious disease this month? We’ve rounded up information on anti-influenza drug research, potential HIV vaccines, and the impacts of chronic viral infections. 

March 11, 2021 / Hokkaido University

Scientists have discovered a route of introduction for High Pathogenicity Avian  Influenza Virus (HPAIV) H5N8 into Japan and, in parallel, have investigated the potential of two human anti-influenza drugs for the control of HPAI in birds.

March 25, 2021 / OHSU

About two decades after first devising a new kind of vaccine, researchers are unlocking why it stops and ultimately clears the monkey form of HIV in about half of nonhuman primates – and why it’s a promising candidate to stop HIV in people. Recent scientific papers describe how unusual biological mechanisms that make the cytomegalovirus vaccine platform work.

March 29, 2021 / Buck Institute

Research suggests that chronic viral infections have a profound and lasting impact on the immune system in ways that are similar to those seen during aging. Using systems immunology and artificial intelligence, researchers profiled and compared immune responses in a cohort of aging individuals, people with HIV on anti-retroviral therapy, and people infected with hepatitis C before and after the virus was treated with a drug that has up to a 97% cure rate.

Thumbnail Preview - Infectious Disease

Download PharPoint’s infectious disease experience overview

[contact-form-7 id=”9108″]